← Back to Search

Antiviral

ABBV-990 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by AbbVie
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to approximately 30 days
Awards & highlights

Study Summary

This trial will assess the safety and pharmacokinetics of ABBV-990 in adult healthy participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to approximately 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to approximately 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AUC From Time 0 to Infinite Time (AUCinf) of ABBV-990
Apparent Terminal Phase Elimination Rate Constant (β) of ABBV-990
Area Under the Plasma Concentration-Time Curve (AUC) From Time 0 to the Time of the Last Measurable Concentration (AUCt) of ABBV-990
+4 more

Trial Design

5Treatment groups
Experimental Treatment
Group I: Group 5Experimental Treatment2 Interventions
Participants will receive ABBV-990 Dose E or matching placebo.
Group II: Group 4Experimental Treatment2 Interventions
Participants will receive ABBV-990 Dose D or matching placebo.
Group III: Group 3Experimental Treatment2 Interventions
Participants will receive ABBV-990 Dose C or matching placebo.
Group IV: Group 2Experimental Treatment2 Interventions
Participants will receive ABBV-990 Dose B or matching placebo.
Group V: Group 1Experimental Treatment2 Interventions
Participants will receive ABBV-990 Dose A or matching placebo.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

AbbVieLead Sponsor
952 Previous Clinical Trials
499,746 Total Patients Enrolled
ABBVIE INC.Study DirectorAbbVie
392 Previous Clinical Trials
144,530 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants
2022. "Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05475821.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top